AstraZeneca PLC (NASDAQ:AZN)
| 66.19 Delayed Data As of Nov 25 |  +0.07 / +0.11%Today’s Change | 52.65 Today|||52-Week Range 71.70 | +13.63% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 66.12 |
| Today’s open | 65.95 |
| Day’s range | 65.73 - 66.33 |
| Volume | 88,799 |
| Average volume (3 months) | 6,248,754 |
| Market cap | $205.2B |
Data as of 1:00pm ET, 11/25/2022
Growth & Valuation
| Earnings growth (last year) | -96.76% |
| Earnings growth (this year) | +25.46% |
| Earnings growth (next 5 years) | +13.75% |
| Revenue growth (last year) | +37.11% |
| P/E ratio | 103.4 |
| Price/Sales | 4.39 |
| Price/Book | 5.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +1.08 | +0.92% |
| NVSNovartis | +0.49 | +0.56% |
| BMYBristol-Myers Squibb | +0.12 | +0.15% |
| MRKMerck | +0.64 | +0.60% |
Data as of 1:10pm ET, 11/25/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $0.71 |
| Annual revenue (last year) | $37.8B |
| Annual profit (last year) | $112.0M |
| Net profit margin | 0.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
